Mostrando 6 resultados de: 6
Publisher
Revista Latinoamericana de Hipertension(3)
American Journal of Therapeutics(2)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Área temáticas
Enfermedades(6)
Farmacología y terapéutica(3)
Fisiología humana(2)
Salud y seguridad personal(2)
Fisiología y materias afines(1)
Área de conocimiento
Enfermedad cardiovascular(5)
Medicamento(2)
Biología molecular(1)
Bioquímica(1)
Genética(1)
Origen
scopus(6)
Cigarette smoking and cardiovascular disease
ReviewAbstract: Cigarette smoking is considered a risk factor for many diseases especially for cardiovascular diseasPalabras claves:Cardiovascular disease, risk factor, smokingAutores:Aguirre M.A., Aparicio D., Bustamante M., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Urdaneta A., Valmore Bermúdez, Velasco M.Fuentes:scopusInfection, inflammation and atherosclerotic vascular disease
ReviewAbstract: Cardiovascular disease (CVD) is the leading cause of death in developed countries. The causes of thiPalabras claves:atherosclerosis, Cardiovascular disease, Chlamydia, infection, inflammation, risk factorAutores:Aparicio D., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Martínez Y., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusSingle-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: Insulin resistance and type 2 diabetes mellitus candidate genes
ArticleAbstract: It has already been a decade and a half since the discovery of adiponectin and its role as an insuliPalabras claves:adiponectin, Insulin Resistance, Leptin resistance, obesity, Type 2 DiabetesAutores:Arráiz N., Canelón R., Pacheco M., Rodríguez-Molina D., Rojas E.R., Rojas-Quintero J., Suárez-Ognio L., Toledo A.C., Valmore Bermúdez, Vega K., Velasco M.Fuentes:scopus